Less Aggressive Chemoradiation for MIBC Tested in Noncystectomy Patients
A study tested a less aggressive chemoradiation protocol in patients with muscle-invasive bladder cancer (MIBC) unfit for surgery due to older age or comorbidities.
Diagnosis & Disease Information
AACR Cancer Progress Report Reveals 33% Decrease in Cancer Death Rate, 1990 to 2020
Report highlights advances such as approval of 14 new anticancer therapeutics, expansion of use of 12 previously approved therapeutics
Adding Ipilimumab to Nivolumab Doesn’t Provide Meaningful Benefit, Researchers Say
Adding ipilimumab to treatment with nivolumab does not provide a clinically meaningful benefit in patients with certain cancers, a meta-analysis suggests.
Cancer Patients More Likely to Die From Early Omicron Variants of SARS-CoV-2
Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.
Administrative Tasks Required to Pay for Cancer Care May Prompt Nonadherence
The burden of administrative tasks required to pay for cancer care is associated with nonadherence to care, a new study suggests.
Bacillus Calmette-Guérin for Bladder Cancer Tied to Lower Dementia Risk
Investigators reviewed the latest studies examining the association between BCG administration and the risk of Alzheimer disease and other dementia in patients with bladder cancer.
US Cancer Death Rates on the Decline, but Urban/Rural Divide Persists
Cancer death rates have declined in the United States in recent years, but the declines are greater in urban than in rural areas, data suggest.
Perioperative Durvalumab Deemed Promising for Muscle-Invasive Urothelial Carcinoma
Adding durvalumab to standard treatment for resectable, muscle-invasive urothelial carcinoma produces promising outcomes, according to researchers.
Deaths Among Cancer Patients Increased During the First 2 Years of the COVID-19 Pandemic
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Urine-Based DNA Methylation Test Can Detect Bladder Cancer
PENK methylation test has high sensitivity and specificity for detecting bladder cancer in patients with hematuria
- Loading...
Loading...
Next post in Bladder Cancer
Loading... 
Loading...